Welcome to our dedicated page for MOLINA HEALTHCARE SEC filings (Ticker: MOH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Molina Healthcare, Inc. filings document the regulatory record for a managed healthcare company serving Medicaid, Medicare and state insurance marketplace programs. Its 8-K reports disclose operating results, premium revenue and earnings guidance, Regulation FD investor presentations, material agreements, direct financial obligations, impairment charges and senior unsecured note financing.
The company's proxy and governance filings cover annual meeting proposals, director and executive compensation matters, equity incentive plan authorization and amendments to charter or bylaw provisions such as stockholder special-meeting rights. The filing record also describes capital-structure terms, credit agreement covenants, risk-factor references and shareholder voting outcomes.
Molina Healthcare, Inc. (MOH) reports that a group of related investment entities led by Giovanni Agnelli B.V. and Exor N.V., through Lingotto Investment Management entities, has filed a Schedule 13G for its holdings in Molina common stock. The group beneficially owns 2,718,348 shares of common stock, representing 5.21% of the outstanding class, with sole voting and dispositive power over these shares and no shared power. The percentage is based on 52,200,000 common shares outstanding as reported in Molina’s Form 10-Q filed on July 23, 2026.
AQR Capital Management, LLC and its parent AQR Capital Management Holdings, LLC report beneficial ownership of 3,560,601 shares of Molina Healthcare, Inc. common stock on this amended Schedule 13G. This represents 6.83% of Molina Healthcare’s outstanding common stock.
The AQR entities report shared voting power over 3,445,027 shares and shared dispositive power over all 3,560,601 shares, with no sole voting or dispositive power. AQR Capital Management, LLC is a wholly owned subsidiary of AQR Capital Management Holdings, LLC.
Capital World Investors, a division of Capital Research and Management Company and related investment management entities, reports beneficial ownership of 2,565,713 shares of Molina Healthcare, Inc. common stock. This represents 4.9% of the 52,100,000 shares believed to be outstanding.
Capital World Investors reports sole voting power and sole dispositive power over all 2,565,713 shares, with no shared voting or dispositive power. The filing is an amendment indicating ownership of 5 percent or less of the class.
FMR LLC filed an amended Schedule 13G reporting beneficial ownership of 1,871,290.18 shares of Molina Healthcare Inc. common stock, representing 3.6% of the class as of June 30, 2026. FMR reports sole dispositive power over all 1,871,290.18 shares and sole voting power over 1,797,102.13 shares, with no shared voting or dispositive power.
Abigail P. Johnson is reported with sole dispositive power over the same 1,871,290.18 shares and no voting power, reflecting her control relationship to FMR LLC. One or more other persons may have rights to dividends or sale proceeds in these shares, but no such person has an interest exceeding 5% of Molina Healthcare’s outstanding common stock.
Molina Healthcare, Inc. reported second quarter 2026 GAAP diluted EPS of $1.19 and adjusted diluted EPS of $1.51, as total revenue reached $10.9 billion. GAAP net income was $60 million, a 76% year‑over‑year decrease, with consolidated MCR at 92.2% versus 90.4% a year earlier.
Premium revenue was $10.2 billion, a 6% year‑over‑year decrease, on membership of about 4.9 million. Operating cash flow for the first half of 2026 was $788 million compared with a $112 million outflow a year earlier, and days in claims payable were 44.
The company reaffirmed full‑year 2026 premium revenue guidance of about $42 billion and increased GAAP EPS guidance to at least $2.15 and adjusted EPS to at least $5.25 per diluted share. Guidance includes an estimated loss of $1.50 per share from the new Florida Medicaid contract and $1.00 per share related to exiting the traditional MAPD product.
ZORETIC RICHARD C reported acquisition or exercise transactions in this Form 4 filing.
Director Richard C. Zoretic received a grant of 237 shares of Molina Healthcare common stock, awarded under the company’s 2025 Equity Incentive Plan for his board service. The award reflects a $55,000 quarterly portion of a $220,000 annual equity package, valued at a closing price of $232.55 per share. All 9,389 shares reported after the transaction are held indirectly through the Richard Charles Zoretic Revocable Living Trust.
WOLF DALE B reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare director Dale B. Wolf received an equity grant of 237 shares of common stock, awarded through a trust, as part of his board compensation. The grant was made under the 2025 Equity Incentive Plan, valued at $55,000 based on the $232.55 closing price on July 1, 2026, bringing indirect holdings to 15,633 shares.
Schapiro Richard M reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare director Richard M. Schapiro received a stock grant as part of his board compensation. He was awarded 237 shares of common stock on July 1, 2026 under the company’s 2025 Equity Incentive Plan, valued at $55,000 based on the closing price of $232.55 per share.
The filing explains this is one quarter of an annual equity award of $220,000 to each director, granted in four equal quarterly installments. Following this award, Schapiro directly holds 12,311 shares of Molina Healthcare common stock, reflecting ongoing, routine equity-based compensation for his service as a director.
ROMNEY RONNA reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare director Ronna Romney received a stock grant through her revocable trust as part of routine board compensation. The trust was awarded 237 shares of common stock under the 2025 Equity Incentive Plan, based on the July 1, 2026 closing price of $232.55 per share.
This quarterly grant represents an equity value of $55,000, one quarter of a $220,000 annual equity award for directors. Following this award, the Ronna Romney Revocable Trust holds a total of 17,869 Molina Healthcare shares, reflecting ongoing compensation rather than an open-market purchase or sale.